Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Pre-publication history

KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study

Jasmina-Ziva Cerne, Vida Stegel, Ksenija Gersak and Srdjan Novakovic*

BMC Cancer 2012, 12:105  doi:10.1186/1471-2407-12-105

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 07 Nov 2011
Reviewer's Report Andreas Hadjisavvas 27 Jan 2012
Reviewer's Report Julia Starmann 01 Feb 2012
Resubmission - Version 2 Manuscript Author's comment 28 Feb 2012
Resubmission - Version 3 Manuscript 28 Feb 2012
Reviewer's Report Julia Starmann 05 Mar 2012
Editorial acceptance 06 Mar 2012
Published 22 Mar 2012